Technology ID
TAB-4627

Streptococcus pneumoniae Invasive and Non-invasive Clinical Isolates for Various Diagnostic and Therapeutic Uses

E-Numbers
E-040-2016-0
Lead Inventor
Beall, Bernard
Lead IC
CDC
Co-Inventors
McGee, Lesley
ICs
CDC
Applications
Vaccines­­­
Therapeutics
Research Materials
Diagnostics
Therapeutic Areas
Respiratory
Pulmonology
Infectious Disease
Immunology
Development Stages
Pre-Clinical (in vitro)
Research Products
Research Equipment
Human Cell Lines

This technology includes Streptococcus pneumoniae isolates collected through CDC’s Global Strain Bank project with particular serotypes. They were collected as part of routine clinical and surveillance activities and have a wide variety of uses including research, diagnostic, and the development of therapeutics.

Commercial Applications
The isolates can be used for therapeutics, diagnostics, and commercial research use.

Competitive Advantages
Repository of S. pneumoniae isolates from invasive and non-invasive disease with confirmed serotypes.
Licensing Contact:
Motley, Jonathan
jonathan.motley@nih.gov